Abstract
Midodrine is commonly used to assist PoTS symptoms. It is an alpha-adrenergic vasoconstrictor, increasing cardiac filling thus improving pre-load. It is short-acting and need to be taken several times a day for efficacy. It has few major side-effects but care needs to be taken to ensure that it does not produce hypertension, particularly when supine. It has few major drug-drug interactions. There are a number of short-term studies highlighting benefit but there are no long-term studies of efficacy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Raj SR, Faris PD, McRae M, Sheldon RS. Rationale for the prevention of syncope trial IV: Assessment of midodrine. Clin Auton Res. 2012;22(6):275–80.
Midodrine, for severe orthostatic hypotension. Drug Ther Bull. 2016;54(5):54–6.
Glatter KA, Tuteja D, Chiamvimonvat N, Hamdan M, Park JK. Pregnancy in postural orthostatic tachycardia syndrome. PACE Pacing Clin Electrophysiol. 2005;28(6):591–3.
Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Can J Cardiol. 2020; 36(3):357–72. https://doi.org/10.1016/j.cjca.2019.12.024.
Gordon VM, Opfer-Gehrking TL, Novak V, Low PA. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res. 2000;10(1):29–33.
Lai CC, Fischer PR, Brands CK, Fisher JL, Porter C-BJ, Driscoll SW, et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol [Internet]. 2009 [cited 2019 Nov 27];32(2):234–8. https://www.ncbi.nlm.nih.gov/pubmed/19170913.
Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G. Treatment of postural tachycardia syndrome: A comparison of octreotide and midodrine. Clin Auton Res. 2006;16(6):390–5.
Zhao J, Tang C, Jin H, Du J. Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children. J Pediatr [Internet]. 2014 [cited 2019 Nov 27];165(2):290–294.e1. https://www.ncbi.nlm.nih.gov/pubmed/24857518.
Yang J, Zhao J, Du S, Liu D, Fu C, Li X, et al. Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride. J Pediatr. 2013;163(4).
Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C, et al. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol [Internet]. 2012 [cited 2019 Nov 27];60(4):315–20. https://www.ncbi.nlm.nih.gov/pubmed/22813609.
Liao Y, Yang J, Zhang F, Chen S, Liu X, Zhang Q, et al. Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. Am J Cardiol [Internet]. 2013 [cited 2019 Nov 27];112(6):816–20. https://www.ncbi.nlm.nih.gov/pubmed/23735645.
Chen L, Wang L, Sun J, Qin J, Tang C, Jin H, et al. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J [Internet]. 2011 [cited 2019 Nov 27];75(4):927–31. https://www.ncbi.nlm.nih.gov/pubmed/21301135.
Ross AJ, Ocon AJ, Medow MS, Stewart JM. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci. 2014;126(4):289–96.
2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope | Heart Rhythm Society [Internet]. [cited 2019 Nov 27]. https://www.hrsonline.org/clinical-resources/2015-heart-rhythm-society-expert-consensus-statement-diagnosis-and-treatment-postural-tachycardia.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gall, N. (2021). Midodrine. In: Gall, N., Kavi, L., Lobo, M.D. (eds) Postural Tachycardia Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-54165-1_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-54165-1_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54164-4
Online ISBN: 978-3-030-54165-1
eBook Packages: MedicineMedicine (R0)